GlassScriptPhysician profile
Richard Harold Smith
NPI 1760422885
$6,936.15
in general payments reported to CMS, 2019-2025
49 companies · $760 in 2025
The $760 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,029 · 2020: $1,076 · 2021: $1,067 · 2022: $1,038 · 2023: $949 · 2024: $1,018 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,632 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,631.78 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $799.63 | 2020-2025 | Vraylar, Qulipta, Ubrelvy |
| Pfizer INC. | $768.40 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $658.30 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $469.99 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $451.28 | 2019-2024 | Veozah, Myrbetriq |
| Lilly USA, LLC | $392.51 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $384.47 | 2020-2024 | Freestyle Libre |
| Allergan, INC. | $383.64 | 2019-2020 | |
| Amgen INC. | $368.08 | 2019-2024 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $237.43 | 2019-2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $197.96 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.15 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $148.58 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $126.91 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $118.82 | 2019-2022 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.